+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

ß-NMN Supplements Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128323
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The β-NMN Supplements Market is projected to reach USD 1.12 Billion in 2026. It is expected to continue growing at a CAGR of 10.55%, reaching USD 2.12 Billion by 2032.

β-NMN Supplements: Executive Overview

β-NMN supplements are positioned within the broader longevity, healthy-aging, and nutritional-supplement landscape. Interest is shaped by consumer attention to cellular energy, age-related wellness, preventive health, and evidence-based supplementation. Market development depends on product quality, regulatory interpretation, scientific credibility, transparent labeling, and responsible communication of benefits and limitations.

Scientific Scrutiny and Consumer Expectations Are Reshaping the Category

The category is undergoing a shift from novelty-led demand toward trust-led adoption. Consumers, clinicians, retailers, and regulators increasingly expect authenticated ingredients, consistent formulations, clear dosage information, contaminant controls, and substantiated claims. Research progress may improve understanding of β-NMN biology, but unresolved questions regarding long-term supplementation, bioavailability, optimal use, and clinically meaningful outcomes continue to require careful interpretation.

Artificial Intelligence Strengthens Discovery, Quality, and Personalization

Artificial intelligence can support β-NMN supplement development by accelerating literature review, identifying research gaps, analyzing formulation and stability data, and improving quality-control workflows. It can also help personalize educational content and flag potentially misleading claims. However, AI-generated conclusions require validation through qualified scientific review, controlled studies, reliable datasets, and compliance checks; automation should not replace clinical judgment or regulatory oversight.

Regional Insights Reflect Different Regulatory and Wellness Environments

North America is characterized by strong interest in preventive wellness, direct-to-consumer education, and supplement innovation, alongside close attention to structure-function claims and product quality. Europe places greater emphasis on harmonized safety expectations, authorized claims, traceability, and consumer protection. Asia-Pacific combines advanced nutraceutical ecosystems with growing healthy-aging interest and diverse national rules. Latin America is influenced by expanding wellness access, retail modernization, and varying enforcement capacity. The Middle East shows growing interest in premium health products, while the African market reflects uneven distribution infrastructure, affordability considerations, and a need for trusted health information.

Economic and Policy Groups Create Distinct Operating Contexts

ASEAN presents a diverse regulatory and consumer environment in which cross-border commercialization requires country-level review. BRICS economies combine large and varied consumer bases with differing approaches to supplements, imports, evidence, and labeling. The European Union emphasizes coordinated safety and claims principles, although implementation and commercial conditions can differ by member state. G7 markets generally feature mature quality expectations, sophisticated consumers, and strong scrutiny of substantiation. GCC countries offer premium wellness opportunities but require careful attention to import, registration, language, and halal-related considerations. NATO members do not form a single supplement regime, so businesses must treat national requirements independently despite shared interest in supply-chain resilience and product integrity.

Country-Level Differences Matter for Compliance and Commercialization

Australia emphasizes therapeutic-goods oversight and evidence-sensitive positioning. Brazil requires attention to national sanitary rules, Portuguese labeling, and local distribution practices. Canada applies a defined natural-health-product framework, while China combines substantial wellness interest with detailed registration, advertising, and cross-border-commerce considerations. France, Germany, Italy, and Spain operate within the European regulatory environment while retaining important national market and enforcement characteristics. India requires careful review of food, nutraceutical, advertising, and import requirements. Japan and South Korea have sophisticated functional-food and wellness sectors with distinct claim and notification approaches. Mexico combines growing supplement demand with local labeling and sanitary obligations. Russia presents specific trade, registration, and distribution complexities. The United Kingdom maintains a separate post-EU regulatory context. The United States permits broad supplement commercialization but closely scrutinizes safety, manufacturing practices, labeling, and disease-related claims.

Build Trust Through Evidence, Quality Systems, and Responsible Positioning

Industry leaders should prioritize identity testing, supplier qualification, batch traceability, stability monitoring, and independent verification before expanding distribution. Communications should distinguish established findings from emerging research and avoid implying that β-NMN treats, prevents, or reverses disease. Organizations should maintain country-specific regulatory assessments, review claims with scientific and legal specialists, and provide accessible information on intended use, dosage, contraindications, and adverse-event reporting. Partnerships with qualified researchers and healthcare professionals can improve credibility, while post-market monitoring can identify quality or safety issues early.

Methodology: Structured Review of Evidence, Regulation, and Market Conditions

This executive summary uses a structured qualitative approach focused on the β-NMN supplement category. The assessment considers peer-reviewed scientific themes, publicly available regulatory principles, supplement-quality practices, consumer-health dynamics, and regional operating conditions. Findings are synthesized across the specified regions, economic and policy groups, and countries. Because evidence and rules can change, product-specific decisions should be supported by current official guidance, laboratory documentation, and qualified professional review.

Responsible Evidence Development Will Define Sustainable Progress

β-NMN supplements occupy an evolving intersection of nutritional science, longevity interest, and regulated consumer health. Durable progress will depend less on aggressive claims than on reproducible evidence, consistent manufacturing, transparent communication, and jurisdiction-aware compliance. Leaders that treat scientific uncertainty responsibly while investing in quality and education will be better positioned to support informed consumer choices and long-term category credibility.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. ß-NMN Supplements Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Liquid
7.4. Powder
7.5. Tablets
8. ß-NMN Supplements Market, by Dosage Range
8.1. Introduction
8.2. 125-250 Mg
8.3. 250-500 Mg
8.4. Above 500 Mg
8.5. Below 125 Mg
9. ß-NMN Supplements Market, by Price Tier
9.1. Introduction
9.2. Economy
9.3. Mid Market
9.4. Premium
10. ß-NMN Supplements Market, by Application
10.1. Introduction
10.2. Anti Aging
10.3. Cardiovascular Health
10.4. Energy Metabolism
10.5. Neuroprotection
11. ß-NMN Supplements Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Retail
11.3.1. Brand Website
11.3.2. Marketplaces
11.3.3. Third Party Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
11.5. Specialty Stores
12. ß-NMN Supplements Market, by End User
12.1. Introduction
12.2. Athletes
12.3. Beauty Enthusiasts
12.4. Elderly
12.5. General Population
13. ß-NMN Supplements Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. ß-NMN Supplements Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. ß-NMN Supplements Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bontac Bio-engineering Co., Ltd.
17.2. Cymbiotika, Inc.
17.3. EffePharm Co., Ltd. / INNOBIO Co., Ltd.
17.4. GeneHarbor Limited
17.5. Genex Formulas, LLC
17.6. Glac Biotech Co., Ltd.
17.7. Herbalmax, Inc.
17.8. IFF Health, Inc.
17.9. Life Extension, Inc.
17.10. New Zealand Longevity Labs Limited
17.11. Nutricost, LLC
17.12. ProHealth Longevity, Inc.
17.13. Renue By Science, LLC
17.14. Shinkowa Pharmaceutical Co., Ltd.
17.15. Wonderfeel, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global ß-NMN Supplements Market, Years Considered for the Study
FIGURE 2. Global ß-NMN Supplements Market, Research Design
FIGURE 3. Global ß-NMN Supplements Market, Research Framework
FIGURE 4. Global ß-NMN Supplements Market, Data Triangulation
FIGURE 5. Global ß-NMN Supplements Market Size, 2017-2032 (USD Million)
FIGURE 6. Global ß-NMN Supplements Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global ß-NMN Supplements Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global ß-NMN Supplements Market Size, by Dosage Range, 2025 vs 2032 (%)
FIGURE 9. Global ß-NMN Supplements Market Size, by Dosage Range, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global ß-NMN Supplements Market Size, by Price Tier, 2025 vs 2032 (%)
FIGURE 11. Global ß-NMN Supplements Market Size, by Price Tier, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global ß-NMN Supplements Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global ß-NMN Supplements Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global ß-NMN Supplements Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global ß-NMN Supplements Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global ß-NMN Supplements Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global ß-NMN Supplements Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global ß-NMN Supplements Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global ß-NMN Supplements Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global ß-NMN Supplements Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global ß-NMN Supplements Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global ß-NMN Supplements Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global ß-NMN Supplements Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global ß-NMN Supplements Market Segmentation & Coverage
TABLE 2. Global ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 3. Global ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 17. Global 125-250 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 125-250 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 125-250 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global 250-500 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global 250-500 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global 250-500 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Above 500 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Above 500 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Above 500 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Below 125 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Below 125 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Below 125 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 30. Global Economy Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Economy Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Economy Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Mid Market Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Mid Market Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Mid Market Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Premium Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Premium Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Premium Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Anti Aging Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Anti Aging Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Anti Aging Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cardiovascular Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cardiovascular Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cardiovascular Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Energy Metabolism Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Energy Metabolism Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Energy Metabolism Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Neuroprotection Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Neuroprotection Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Neuroprotection Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 53. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Online Retail Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Online Retail Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Online Retail Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Brand Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Brand Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Brand Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Marketplaces Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Marketplaces Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Marketplaces Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Third Party Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Third Party Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Third Party Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Specialty Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Specialty Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Specialty Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Global Athletes Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Athletes Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Athletes Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Beauty Enthusiasts Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Beauty Enthusiasts Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Beauty Enthusiasts Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Elderly Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Elderly Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Elderly Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global General Population Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global General Population Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global General Population Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. North America ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. North America ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 105. North America ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 106. North America ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 107. North America ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. North America ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. North America ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 110. North America ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 111. North America ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Latin America ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Latin America ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 114. Latin America ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 115. Latin America ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 116. Latin America ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Latin America ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Latin America ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 119. Latin America ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 120. Latin America ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Europe ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Europe ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 123. Europe ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 124. Europe ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 125. Europe ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Europe ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Europe ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 128. Europe ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 129. Europe ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Middle East ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Middle East ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 132. Middle East ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 133. Middle East ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 134. Middle East ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Middle East ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Middle East ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 137. Middle East ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 138. Middle East ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Africa ß-NMN Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Africa ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 141. Africa ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 142. Africa ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 143. Africa ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Africa ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. Africa ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 146. Africa ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 147. Africa ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Global ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 151. ASEAN ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 152. ASEAN ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 153. ASEAN ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. ASEAN ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. ASEAN ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 156. ASEAN ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 157. ASEAN ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. GCC ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. GCC ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 160. GCC ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 161. GCC ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 162. GCC ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. GCC ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. GCC ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 165. GCC ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 166. GCC ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. European Union ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. European Union ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 169. European Union ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 170. European Union ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 171. European Union ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. European Union ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. European Union ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 174. European Union ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 175. European Union ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. BRICS ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. BRICS ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 178. BRICS ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 179. BRICS ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 180. BRICS ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. BRICS ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. BRICS ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 183. BRICS ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 184. BRICS ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. G7 ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. G7 ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 187. G7 ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 188. G7 ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 189. G7 ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. G7 ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. G7 ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 192. G7 ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 193. G7 ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. NATO ß-NMN Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. NATO ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 196. NATO ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 197. NATO ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 198. NATO ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. NATO ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. NATO ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 201. NATO ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 202. NATO ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Global ß-NMN Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. United States ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 205. United States ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 206. United States ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 207. United States ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 208. United States ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. United States ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. United States ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 211. United States ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 212. United States ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Canada ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 214. Canada ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 215. Canada ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 216. Canada ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 217. Canada ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Canada ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Canada ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 220. Canada ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 221. Canada ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Mexico ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 223. Mexico ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 224. Mexico ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 225. Mexico ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 226. Mexico ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Mexico ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Mexico ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 229. Mexico ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 230. Mexico ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Brazil ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 232. Brazil ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 233. Brazil ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 234. Brazil ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 235. Brazil ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Brazil ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Brazil ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 238. Brazil ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 239. Brazil ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. United Kingdom ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 241. United Kingdom ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 242. United Kingdom ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 243. United Kingdom ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 244. United Kingdom ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. United Kingdom ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. United Kingdom ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 247. United Kingdom ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 248. United Kingdom ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Germany ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 250. Germany ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 251. Germany ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 252. Germany ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 253. Germany ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Germany ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Germany ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 256. Germany ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 257. Germany ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. France ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 259. France ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 260. France ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 261. France ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 262. France ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. France ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. France ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 265. France ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 266. France ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Russia ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 268. Russia ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 269. Russia ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 270. Russia ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 271. Russia ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Russia ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Russia ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 274. Russia ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 275. Russia ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Italy ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 277. Italy ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 278. Italy ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 279. Italy ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 280. Italy ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Italy ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Italy ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 283. Italy ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 284. Italy ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Spain ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 286. Spain ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 287. Spain ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 288. Spain ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 289. Spain ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Spain ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 291. Spain ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 292. Spain ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 293. Spain ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. China ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 295. China ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 296. China ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 297. China ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 298. China ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. China ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. China ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 301. China ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 302. China ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. India ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 304. India ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 305. India ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 306. India ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 307. India ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. India ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. India ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 310. India ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 311. India ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. Japan ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 313. Japan ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 314. Japan ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 315. Japan ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 316. Japan ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Japan ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. Japan ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 319. Japan ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 320. Japan ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. Australia ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 322. Australia ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 323. Australia ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 324. Australia ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 325. Australia ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. Australia ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. Australia ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 328. Australia ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 329. Australia ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. South Korea ß-NMN Supplements Market Size, 2017-2032 (USD Million)
TABLE 331. South Korea ß-NMN Supplements Market Size, by Form, 2017-2032 (USD Million)
TABLE 332. South Korea ß-NMN Supplements Market Size, by Dosage Range, 2017-2032 (USD Million)
TABLE 333. South Korea ß-NMN Supplements Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 334. South Korea ß-NMN Supplements Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. South Korea ß-NMN Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 336. South Korea ß-NMN Supplements Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 337. South Korea ß-NMN Supplements Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 338. South Korea ß-NMN Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. Global ß-NMN Supplements Market Share, by Key Player, 2025
TABLE 340. Global ß-NMN Supplements Market, Key Experts

Companies Mentioned

  • Bontac Bio-engineering Co., Ltd.
  • Cymbiotika, Inc.
  • EffePharm Co., Ltd. / INNOBIO Co., Ltd.
  • GeneHarbor Limited
  • Genex Formulas, LLC
  • Glac Biotech Co., Ltd.
  • Herbalmax, Inc.
  • IFF Health, Inc.
  • Life Extension, Inc.
  • New Zealand Longevity Labs Limited
  • Nutricost, LLC
  • ProHealth Longevity, Inc.
  • Renue By Science, LLC
  • Shinkowa Pharmaceutical Co., Ltd.
  • Wonderfeel, Inc.